HIGHLIGHTS FROM MED TECH WEEK 2017

#MedTechWeek 2017 activities out now! 

From 19 – 23 June   IMSTA , Medtech companies and Trade Associations from across Europe joined together to communicate the value that medical devices and in vitro diagnostics deliver to people, health systems and the wider economy.   IMSTA participated in several events during this week and the lightlights can be enjoyed below.

 

IMSTA are newest partners to donation scheme – The EQUALS Initiative.  The EQUALS Initiative was established between The Royal College of Physicians of Ireland and the HSE, and is based on developing strong links with hospitals while providing support according to the needs identified for equipment and training – 50 in-patient beds, 20 labour and delivery ward beds and 10 ultrasound machines being donated.  Details of the latest EQUALS Initiative were confirmed today as part of 2017 #medtechweek which is being hosted by IMSTA.

Speaking today, Justin Carty of IMSTA said: We are delighted to be on board with this positive and virtuous initiative as it continues to go from strength to strength. Many of our members in the medical technology sector would have supplied the equipment being donated and they will be heartened to know that it can still have a significant impact after being taken out of service in Ireland.   IMSTA’s access to medical equipment coupled with our bioengineering expertise can support the work of EQUALS in donating equipment and providing training in equipment maintenance in Zambia and other less developed countries.  This will enable hospitals in these countries to provide essential safe and high-quality health care which will address medical needs and save lives.”

“IMSTA recognizes the vital role of medical technology in contributing to the development of healthcare services and to address the unmet equipping and training needs in less developed countries.  Alike with our partners on EQUALS, we are deeply committed to the common goal of contributing to the improvement of global health.

Launching the new collaboration with IMSTA, Professor Frank Murray, President of the Royal College of Physicians of Ireland, said: “The healthcare and training needs are substantial in Zambia. We see opportunities to improve outcomes there in partnership with the authorities in Zambia. Healthcare equipment from Ireland has a huge potential to deliver benefits in Zambia. We look forward to collaborating with IMSTA to optimize opportunities to benefit Zambian patients. RCPI and HSE have developed a significant collaboration around training and equipment in this area, and the involvement of IMSTA has the possibility of bringing this to a higher level. It fulfills part of our mission statement to improve patient outcomes.”

Justin and Prof. Murray were interviewed afterwards on Newstalk’s Global Village programme and you can access the podcast here http://www.newstalk.com/podcasts/Global_Village/Global_Village_Highlights/197173/Health_in_Zambia.

 

To celebrate 2017 MedTech Week in Ireland, the Irish Medical & Surgical Trade Association (IMSTA) joined forces with global brand Vanilla Blush to showcase the company’s fashion and medical range of stoma underwear for patients.

Justin Carty, CEO of the Irish Medical & Surgical Trade Association (IMSTA) said: “Vanilla Blush’s specially designed underwear support and conceal stoma bags, which greatly improves patient experiences allowing people with stoma bags to live full normal lives. IMSTA believes in supporting products which do just that.  Patient experience matters and is proven to effect health outcomes. Vanilla Blush products are available in the NHS but they are not reimbursed in Ireland by the HSE’s Primary Care Reimbursement System (PCRS). One has to ask why? It is our hope that this will change and these products will be reimbursed to Irish patients in time.”

Nicola Dames, the Dublin-born Vanilla Blush CEO, added: “We all have specialised individual needs. And we all have individual medical technological help. I so happen to need additional support with my Stoma. Other people need other help. This is what I call a normality of needs.”

Justin Carty, IMSTA, participated in a roundtable discussion, hosted by Medtronic, to mark MedTech Week 2017 on Tuesday June 20th at Buswells Hotel.   

DUBLIN – June 20, 2017 82% of Irish men and women have said they want easier access to innovative surgical treatments to treat incontinence and support a better quality of life, according to new research by Medtronic plc (NYSE: MDT).

The research was carried out by iReach, on behalf of Medtronic to mark MedTech Week 2017, with 1001 people (48% male, 52% female) across Ireland sampled from the 26th May to 1st June 2017 using an online survey and a consumer panel.

The data, presented at a MedTech Week event, has also found that:

  • Just 35% would be comfortable reporting their incontinence problems to a nurse, 32% to a consultant, 14% to a friend and 11% to a physiotherapist. Just 39% of adults surveyed would be comfortable talking about their incontinence to a family member and 14% to a friend.
  • 55% of respondents are likely to accept non-invasive surgical treatment in order to resolve issues with incontinence, with 50% of respondents also willing to consider physiotherapy;
  • Compared to all cohorts, middle-aged adults are most likely to favour non-invasive surgical treatments, with 61% of males selecting this treatment option as a means to resolve issues with incontinence;

To celebrate MedTech Week 2017, Medtronic also hosted a roundtable discussion to consider the research findings with patient groups, clinicians and representatives of the medical technology sector.  Participants emphasised that incontinence remains an under-treated condition as Irish patients remain uncomfortable in seeking treatment, as the research has revealed, and supported a call for the Irish healthcare system to harness the potential of innovative incontinence treatments to enhance patient outcomes. There was also agreement in calling for the optimisation of care pathways to ensure the most comprehensive treatments for pelvic floor disorders are available to patients in Ireland.

In a subsequent parliamentary exhibition, which was attended by TDs, Senators and patients, innovative bladder and bowel control therapies enabled by medical technology were put on display. Attendees were also given a first-hand account of how the use of such therapies can bring about significant improvements in the quality of life of incontinence sufferers. 

Speaking at the event, Dr. Mary Pat Fitzgerald, Consultant Gynaecologist at Bon Secours Hospital Galway, said: “Bladder control problems can significantly impair the quality of our lives, and as our discussions today have shown many patients are too embarrassed or uncomfortable to talk about the problem with a medical professional. It is critically important that we bring this condition out in the open so another generation does not suffer in silence.”

Dr. Eleanor Faul, Consultant Colorectal Surgeon at the Mater Misericordiae University Hospital said: “Today’s event is much needed to raise awareness of incontinence and the range of innovative therapies that are available for Irish patients. Technological advancements are enabling the development of new treatment options for those suffering with a loss of bowel control. Moreover, the clinical benefits of surgical technology are clear; they often relieve symptoms when other treatments fail and give a new lease of life to silent sufferers across Ireland.” 

Jackie Fielding, Vice President UK and Ireland at Medtronic, said: “MedTech Week 2017 is an important opportunity for Medtronic to highlight the value of medical technologies. Ireland has a leading role in the vibrant European MedTech industry and there is a need to draw greater awareness to the innovative surgical treatments available. We hope that by partnering with patient groups and clinicians in Ireland in the area of incontinence our MedTech Week event will help bring greater attention to the options available to those affected by incontinence to ensure they no longer suffer in silence.”